Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fundely CoTSE:3137 +0.97%55 EBITDA Margin % is 38.77% as of Mar. 2026, which is 188% above its 10-year median of 13.47. GuruFocus rates TSE:3137 with a GF Score™ of 55/100 and a GF Value™ of 円170.54 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 1,010 Media - Diversified companies, Fundely Co ranks better than 61.58% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Fundely Co's EBITDA for the
three
months ended in Mar. 2026 was 円257 Mil. Fundely Co's Revenue for the
three
months ended in Mar. 2026 was 円663 Mil. Therefore, Fundely Co's EBITDA margin for the quarter that ended in Mar. 2026 was 38.77%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Fundely Co EBITDA Margin % Related Terms
Fundely Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Fundely Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Publishing subindustry, Fundely Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fundely Co EBITDA Margin % vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Fundely Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Fundely Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fundely Co (TSE:3137) has a EBITDA Margin % of 38.77% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Fundely Co and its competitors. This is 188% above median its historical median of 13.47. According to the industry distribution chart, Fundely Co ranks #388 out of 1010 companies in the Media - Diversified industry, placing it in the top 38.4%.
Is Fundely Co's EBITDA Margin % too high?
Fundely Co's current EBITDA Margin % of 38.77% is 188% above median its 10-year median of 13.47. The Media - Diversified industry median EBITDA Margin % is 8.42. Fundely Co's value of 38.77% is 360.5% above this industry median. Based on the distribution chart, Fundely Co ranks #388 out of 1010 companies in the Media - Diversified industry, which is above the industry midpoint. Overall, Fundely Co has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fundely Co's EBITDA Margin % compare to NYT and WLY?
According to the Media - Diversified industry distribution chart, Fundely Co ranks #388 out of 1010 companies for EBITDA Margin %. This puts Fundely Co in the upper half of its industry. The industry median EBITDA Margin % is 8.42. Fundely Co's value of 38.77% is 360.5% above this benchmark. While the company's 10-year median is 13.47 vs. the industry median of 8.42, Fundely Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Media - Diversified company?
The median EBITDA Margin % among Media - Diversified companies is 8.42, based on 1,010 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fundely Co's current EBITDA Margin % of 38.77% is 360.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Fundely Co and its competitors. For the Media - Diversified industry, the median EBITDA Margin % is 8.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fundely Co's current EBITDA Margin % is 38.77%, which is 188% above median its own 10-year median of 13.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fundely Co stock overvalued right now?
Based on GuruFocus' analysis, Fundely Co (TSE:3137) is currently considered Modestly Overvalued. The stock's GF Value™ is 円170.54, compared to a current price of 円208.00 — trading 22% above its estimated fair value. The current EBITDA Margin % is 38.77%, which is 188% above median its 10-year median of 13.47 and 360.5% above the Media - Diversified industry median of 8.42. Fundely Co's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Fundely Co (TSE:3137), the current EBITDA Margin % is 38.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fundely Co (TSE:3137) Overvalued in 2026?
Based on GuruFocus' analysis, Fundely Co stock appears to be overvalued.
The current stock price of 円208.00 is trading 22% above its estimated GF Value™ of 円170.54.
GuruFocus considers Fundely Co to be Modestly Overvalued.
Key valuation signals for TSE:3137:
EBITDA Margin %: 38.77% (188% above median its 10-year median of 13.47)
GF Value™: 円170.54 vs. price of 円208.00 (22% above fair value)
Industry Position: 360.5% above the Media - Diversified median (#388 of 1010)
No single metric tells the full story. See the TSE:3137 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fundely Co Ltd is engaged in the mail-order and retail sales of food and health-related products, as well as marketing support services. Its operations include the MFD business, which focuses on mail-order sales and catalog publication of healthy foods; the CID business, which handles mail-order and retail sales of frozen foods made with domestically sourced ingredients; and the Marketing business, which provides promotional support to food manufacturers and related entities using the company's media and networks with medical institutions. It generates the majority of its revenue from the MFD business segment.
55GF Score
Get the complete analysis for TSE:3137
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3137 has been successfully added to your 
